The use of clodronate in multiple myeloma

This publication has 12 references indexed in Scilit:

• Abnormal serum bone gla protein levels in multiple myeloma: Crucial role of bone formation and prognostic implications
  Cancer, 1990
• LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPY
  Hematological Oncology, 1990
• Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells
  Blood, 1989
• Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma
  Blood, 1989
• Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
  Blood, 1989
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
  Nature, 1988
• Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
  New England Journal of Medicine, 1987
• Serum bone gla-protein in multiple myeloma
  Cancer, 1987
• Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
  Metabolic Bone Disease and Related Research, 1982
• Evidence for the Secretion of an Osteoclast Stimulating Factor in Myeloma
  New England Journal of Medicine, 1974